CRDF Global is an independent, nonprofit organization dedicated to building a safer, healthier, and more secure world through science, innovation, and collaboration. CRDF Global was founded in 1995 with the mission of bolstering the global scientific community and its research aims, primarily to reduce emerging threats after the collapse of the Soviet Union. Over the course of nearly three decades, CRDF Global has remained a trusted partner to the U.S. and Allied governments and has expanded its work to address ever-changing global concerns and research values. Today, CRDF Global teams mitigate shared global challenges in the areas of international security cooperation, nonproliferation, cybersecurity and digital resilience, global health, food security, economic development, and professional exchanges. With offices in Arlington, Virginia; Amman, Jordan; Kyiv, Ukraine; Warsaw, Poland; Almaty, Kazakhstan; and Manila, Philippines; CRDF Global’s diverse staff and networks of local community and government stakeholders deliver tailored programs that meet specific regional needs in over 100 countries across the globe.

NIH represents one of CRDF Global’s largest and oldest institutional partners. Within NIH’s extensive framework, CRDF Global supports projects and activities associated with the National Institute of Allergy & Infectious Diseases (NIAID), Fogarty International Center (FIC), National Cancer Institute (NCI), and, most recently, FAST-TB. Administrative actions and solutions across these different portfolios are as varied and diverse as the projects themselves, and CRDF Global is proud to remain a consistent and dependable partner that can assist NIH program staff and funding recipients in reaching their goals for reducing health risk and the burden of disease for people around the world.

CRDF Global began its relationship with NIH in 1997, initially supporting FIC by providing one-off and ad hoc program support. Since the late nineties, however, CRDF Global has vastly grown its presence in the global health solutions sector applying services and expertise for more complex projects at a larger scale, ultimately leading to its current relationship and involvement with the Regional Prospective Observational Research for Tuberculosis (RePORT) program today. CRDF Global has been a proud partner of RePORT since 2012, when it began as a bilateral initiative between India – specifically the India Department of Biotechnology (DBT) and the India Council of Medical Research (ICMR) – and the U.S. – specifically NIH under the Indo-US Vaccine Action Program (VAP). Over the past 12 years, RePORT has expanded to include partner countries including Brazil, South Africa, China, the Philippines, Indonesia, South Korea, and most recently, Uganda.

CRDF Global supports RePORT in its advancement of regional TB science that contributes to the global research agenda; strengthens local TB research capacity; and promotes biomedical, clinical, and implementation innovations within each country. CRDF Global is motivated to provide realistic and customizable solutions to help researchers and sites grow their global footprint and technical capacity in the TB research arena while ensuring compliance with NIH and U.S. Government standards and guidelines.

Though CRDF Global ensures ethical and timely grant and contract administration in compliance with 2 CFR 200 regulations for all participating RePORT contributors, its most important function is to deftly navigate the unique and nuanced needs of different projects, their teams, and geopolitical contexts. With its network of global hub offices, CRDF Global is positioned to provide real-time assistance and solutions, which may not always be possible with government institutions or big private sector firms. CRDF Global’s experience and priority on global health missions allows its team the flexibility to work within the diverse contexts or varying capacities required by the NIH, all while operating with strict respect to the organization’s standards of administration.

CRDF Global is proud to support RePORT International projects in achieving their diverse and varied research goals across the consortium. Our team is always available to help constituents navigate complex grant or contract administration hurdles, so awardees may access the tools they need to successfully complete deliverables that may reduce the burden of disease for people around the globe.

CRDF Global excels in bringing the best minds together to tackle diverse issues of global importance as compassionately, ethically, and quickly as possible and to the highest standard, despite the myriad threats and challenges that confront the sector. One notable challenge is the need to continuously recalibrate our tools and strategies to best operate in ever-changing international environments with varying geopolitical climates; in essence, understanding and navigating individual bureaucratic infrastructures, stakeholders with competing interests, and conflicting rules and regulations.

The COVID pandemic has also presented an undeniable challenge to our way of life and, notably, the way of work. Anxieties born over the past few years continue to reverberate, whether it be through the availability of funding and competition for that funding among various organizations, ease and security of travel, or dynamics that impact effective collaboration.

CRDF Global is steadfast in its support to RePORT and confident that the value of our continued collaboration and progress are evident and compelling to future decision-makers and contributors.